TY - JOUR
T1 - Acute gastrointestinal bleeding
T2 - Experience of a specialized management team
AU - Gostout, Christopher J.
AU - Wang, Kenneth K.
AU - Ahlquist, David A.
AU - Clain, Jonathan E.
AU - Hughes, Rollin W.
AU - Larson, M. V.
AU - Petersen, Bret T.
AU - Schroeder, Kenneth W.
AU - Tremaine, William J.
AU - Viggiano, Thomas R.
AU - Balm, Rita K.
PY - 1992/4
Y1 - 1992/4
N2 - The initial experience of a specialized management team organized to provide expedient care for all acute major gastrointestinal bleeding in protocolized fashion at a large referral center is presented. Of the 417 patients, 56% developed bleeding while hospitalized. Upper gastrointestinal bleeding accounted for 82%. The five most common etiologies included gastric ulcers (83 patients), duodenal ulcers (67 patients), erosions (41 patients), varices (35 patients), and diverticulosis (29 patients). Non-steroidal anti-inflammatory drugs were implicated in 53% of gastroduodenal ulcers. The incidence of nonbleeding visible vessels was 42% in gastric and 54% in duodenal ulcers. The rates of rebleeding were 24% (20 patients) in gastric ulcers and 28% (19 patients) in duodenal ulcers. Predictive factors for rebleeding included copious bright red blood, active arterial streaming, spurting, or a densely adherent clot. The rebleeding rate for esophagogastric varices was 57%. The mortality rate overall was 6% (27 patients), with rates varying from 3% (five patients) for gastroduodenal ulcers to 40% (14 patients) for esophagogastric varices. The morbidity rate for the entire patient population was 18% (77 patients), dominated by myocardial events (34 patients). The average length of hospitalization for gastroduodenal ulcers was 5 days, for diverticulosis 8 days, and for varices 10 days. The major efforts of a specialized Gastrointestinal Bleeding Team would be best directed at both reducing the morbidity associated with acute bleeding and reducing the overall cost of care.
AB - The initial experience of a specialized management team organized to provide expedient care for all acute major gastrointestinal bleeding in protocolized fashion at a large referral center is presented. Of the 417 patients, 56% developed bleeding while hospitalized. Upper gastrointestinal bleeding accounted for 82%. The five most common etiologies included gastric ulcers (83 patients), duodenal ulcers (67 patients), erosions (41 patients), varices (35 patients), and diverticulosis (29 patients). Non-steroidal anti-inflammatory drugs were implicated in 53% of gastroduodenal ulcers. The incidence of nonbleeding visible vessels was 42% in gastric and 54% in duodenal ulcers. The rates of rebleeding were 24% (20 patients) in gastric ulcers and 28% (19 patients) in duodenal ulcers. Predictive factors for rebleeding included copious bright red blood, active arterial streaming, spurting, or a densely adherent clot. The rebleeding rate for esophagogastric varices was 57%. The mortality rate overall was 6% (27 patients), with rates varying from 3% (five patients) for gastroduodenal ulcers to 40% (14 patients) for esophagogastric varices. The morbidity rate for the entire patient population was 18% (77 patients), dominated by myocardial events (34 patients). The average length of hospitalization for gastroduodenal ulcers was 5 days, for diverticulosis 8 days, and for varices 10 days. The major efforts of a specialized Gastrointestinal Bleeding Team would be best directed at both reducing the morbidity associated with acute bleeding and reducing the overall cost of care.
KW - Acute gastrointestinal bleeding
KW - Diverticulosis
KW - Peptic ulcers
KW - Therapeutic endoscopy
KW - Visible vessel
UR - http://www.scopus.com/inward/record.url?scp=20244370322&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=20244370322&partnerID=8YFLogxK
U2 - 10.1097/00004836-199204000-00014
DO - 10.1097/00004836-199204000-00014
M3 - Article
C2 - 1564303
AN - SCOPUS:20244370322
SN - 0192-0790
VL - 14
SP - 260
EP - 267
JO - Journal of clinical gastroenterology
JF - Journal of clinical gastroenterology
IS - 3
ER -